---
figid: PMC2956794__nihms232970f1
figtitle: Targeting DNA repair proteins for cancer treatment
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC2956794
filename: nihms232970f1.jpg
figlink: /pmc/articles/PMC2956794/figure/F1/
number: F1
caption: 'Repairing toxic DNA lesions induced during most common cancer treatments
  relies on proper DNA-repair response, which has the ability to dictate the cellular
  outcome, e.g. cell death or cell survival.Triggering of a specific repair pathway
  (DR, BER, NER, MMR, HR and NHEJ pathways) depends on the nature of the DNA damage.
  The main components and the signaling pathways of each repair response is indicated.
  Yellow boxes highlight emerging anticancer targets which are discussed in this issue.
  The availability as anticancer targets of other components of these pathways requires
  further testing. Abbreviations: DR, Direct Reversal; BER, Base Excision Repair;
  NER, Nucleotide Excision Repair; GGR, Global Genome Repair; TCR, Transcription Coupled
  Repair; MMR, Mismatch Repair; HR, Homologous Recombination; MRN, Mre11–Rad50–Nbs1
  complex; NHEJ, Non-Homologous End Joining; O6MeG, O6-methylguanine.'
papertitle: Targeting DNA repair proteins for cancer treatment.
reftext: Gianluca Tell, et al. Cell Mol Life Sci. ;67(21):3569-3572.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9356603
figid_alias: PMC2956794__F1
figtype: Figure
redirect_from: /figures/PMC2956794__F1
ndex: ccdf481b-deea-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2956794__nihms232970f1.html
  '@type': Dataset
  description: 'Repairing toxic DNA lesions induced during most common cancer treatments
    relies on proper DNA-repair response, which has the ability to dictate the cellular
    outcome, e.g. cell death or cell survival.Triggering of a specific repair pathway
    (DR, BER, NER, MMR, HR and NHEJ pathways) depends on the nature of the DNA damage.
    The main components and the signaling pathways of each repair response is indicated.
    Yellow boxes highlight emerging anticancer targets which are discussed in this
    issue. The availability as anticancer targets of other components of these pathways
    requires further testing. Abbreviations: DR, Direct Reversal; BER, Base Excision
    Repair; NER, Nucleotide Excision Repair; GGR, Global Genome Repair; TCR, Transcription
    Coupled Repair; MMR, Mismatch Repair; HR, Homologous Recombination; MRN, Mre11–Rad50–Nbs1
    complex; NHEJ, Non-Homologous End Joining; O6MeG, O6-methylguanine.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Dr
  - ber
  - agt
  - ag
  - tc
  - double
  - Tcr
  - Xpc
  - Cbs
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - Blm
  - Irbp
  - Ku80
  - tefu
  - Xpac
  - RPA3
  - RPA2
  - RPA1
  - mrn
  - CG12728
  - Rad51D
  - spn-B
  - spn-A
  - hay
  - Xpd
  - mus201
  - Rf-c
  - CG8142
  - RfC4
  - Gnf1
  - PCNA
  - DNAlig4
  - okr
  - Brca2
  - polo
  - Parp
  - mms4
  - MMS-4
  - XRCC1
  - DNAlig3
  - Polr2A
  - Prim1
  - PolA1
  - PolA2
  - sv
  - Prim2
  - svr
  - Fen1
  - DNAlig1
  - NR1H2
  - MRC1
  - MGMT
  - AGT
  - AGXT
  - BPIFA4P
  - GCGR
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - H3P2
  - XPC
  - CSH2
  - ERCC6
  - ERCC8
  - CSH1
  - HSPA9
  - XRCC6
  - XRCC5
  - ATM
  - PRKDC
  - XPA
  - MRE11
  - NBN
  - RAD50
  - WDCP
  - RAD52
  - XRCC4
  - RAD51
  - ERCC3
  - ERCC2
  - ERCC5
  - RFC1
  - SLC19A1
  - RFC2
  - RFC3
  - RFC4
  - RFC5
  - LIG4
  - APEX1
  - ATRX
  - BRCA2
  - BRCA1
  - ERVW-4
  - TENT4A
  - PARP1
  - COL11A2
  - PARP2
  - PARP3
  - PARP4
  - PARP6
  - PARP8
  - PARP9
  - PARP10
  - PARP11
  - PARP12
  - PARP14
  - PARP15
  - PARP16
  - TNKS
  - TNKS2
  - TIPARP
  - LIG3
  - LRIG3
  - FEN1
  - LIG1
  - LRIG1
---
